
Trupanion (TRUP) Stock Forecast & Price Target
Trupanion (TRUP) Analyst Ratings
Bulls say
Trupanion is a leading provider of medical insurance plans for cats and dogs, with a strong presence in the United States and Canada. The company's unique ability to accurately price risk and its focus on passing on value to consumers through higher claims payout ratios make it well-positioned for growth in the underpenetrated pet insurance market. Additionally, Trupanion's structural cost advantages allow for a sustainable business model and potential for strong financial performance.
Bears say
Trupanion is facing declining market share, decelerating IRR, and limited growth potential due to its failure to implement broader-reaching plans. Risks to its rating and target price include incorrect assumptions on customer lifetime value, competition, regulatory compliance, claims exceeding reserves, and a lack of comparable publicly traded pet insurance companies. While the company beat earnings and revenue estimates, there is concern about decelerating revenue growth and the potential impact of AI on its business.
This aggregate rating is based on analysts' research of Trupanion and is not a guaranteed prediction by Public.com or investment advice.
Trupanion (TRUP) Analyst Forecast & Price Prediction
Start investing in Trupanion (TRUP)
Order type
Buy in
Order amount
Est. shares
0 shares